The pharmaceutical landscape for diabetes is shifting, and transdermal GLP-1 delivery systems represent a potential advance. Unlike subcutaneous injections, this technique offers a simpler way to administer GLP-1 https://roryokwx282441.blogsumer.com/39901850/glp-1-patches-a-new-approach-to-blood-sugar-treatment